A Randomized, Double-Blind, Placebo-Controlled, Multicentric Study to Evaluate the Efficacy and the Tolerability of a Class II Medical Device in the Treatment of Mild and Moderate Acne
Crossref DOI link: https://doi.org/10.1007/s13555-022-00767-1
Published Online: 2022-07-21
Published Print: 2022-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Fabbrocini, Gabriella
Ferrillo, Maria
Donnarumma, Marianna
Papale, Angela
Pinto, Daniela
Rinaldi, Fabio http://orcid.org/0000-0002-8645-1720
Text and Data Mining valid from 2022-07-21
Version of Record valid from 2022-07-21
Article History
Received: 28 February 2022
Accepted: 27 June 2022
First Online: 21 July 2022